IP Library Granted Patent US 7,846,430
Granted Patent B2
US 7,846,430 · App. 12/039,948 · Granted Dec 7, 2010

Composition and method for treating bovine papilloma virus in equine

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,846,430
App. No.
12/039,948
Granted
Dec 7, 2010
Kind
B2
Abstract

A composition of lysozyme and a pharmaceutically acceptable carrier is active against the papilloma virus in both humans and animals. The composition can be used to treat women suffering from cervical cancer. The composition can also be used to treat cows and horses suffering sarcoids.

Claims (9)

1. A method of treating bovine papilloma virus infection in an equine animal suffering from sarcoids, said method comprising administering to said equine animal an effective amount therefor of a lysozyme for a period of time sufficient to treat said bovine papilloma virus infection.

2. The method according to claim 1 , wherein the lysozyme is administered to the equine animal by topically applying a composition comprising the lysozyme to an area of the equine animal's skin covering one or more of said sarcoids.

3. The method according to claim 2 , wherein the composition comprising the lysozyme is in the form of a sprayable solution or a cream or lotion.

4. The method according to claim 3 , wherein the composition additionally comprises cisplatin.

5. The method according to claim 1 , wherein the lysozyme is administered orally to the animal.

6. The method according to claim 5 , wherein the lysozyme is administered orally to the equine animal in combination with cisplatin.

7. The method according to claim 1 , wherein the equine animal is a horse.

8. A method of shrinking the size of sarcoid tumors in an equine animal suffering from sarcoid tumors, said method comprising administering an effective amount therefor of a lysozyme for a period of time sufficient to shrink said sarcoid tumors.

9. The method according to claim 8 , wherein the equine animal is a horse.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2013
From: BIOSEUTICA B.V.
To: MURAMI PHARMA, INC
Reel/Frame 031067/0280 →
CHANGE OF NAME Recorded Jul 17, 2012
From: RHODES HOLDING NETHERLANDS B.V.
To: BIOSEUTICA B.V.
Reel/Frame 028572/0319 →
MERGER Recorded Jul 16, 2012
From: SAINT SIMEON-MARKETING E INVESTIMENTOS LDA
To: RHODES HOLDING NETHERLANDS B.V.
Reel/Frame 028556/0324 →
Continuity (2)
Provisional Application 6089257300 · Mar 2, 2007
Related Publication 20080213242A1 · Sep 4, 2008